Clinical trial
A Randomized Trial of the Effect of Continuous Glucose Monitoring (CGM) in Individuals With Type 1 Diabetes Treated With Multiple Daily Insulin Injections (MDI)
NCT02092051 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Trial of the Effect of Continuous Glucose Monitoring (CGM) in Individuals With Type 1 Diabetes Treated With Multiple Daily Insulin Injections (MDI)
- Lead sponsor
- Vastra Gotaland Region
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- June 30, 2016
- Enrollment
- 161 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.